Thermo Fisher Scientific Stock News

Key Prominent Players Covered in the Cell Freezing Media Market are Thermo Fisher Scientific, Bio-Rad Laboratories, Abcam Plc, Merck KGaA, BioLifeSolutions Inc., HiMedia Laboratories, AMSBIO, BIOGENUIX MEDSYSTEM PVT.LTD. Key Prominent Players Covered in the Cell Freezing Media Market are Thermo Fisher Scientific, Bio-Rad Laboratories, Abcam Plc, Merck KGaA, BioLifeSolutions Inc., HiMedia Laboratories, AMSBIO, BIOGENUIX MEDSYSTEM PVT.LTD.

Here we look at three stocks, PKI, TMO and TXG, with robust genome sequencing capabilities that investors can keep a watch on.

The Microorganism Identification System Market report is the most important research for those looking for comprehensive information about the Microorganism Identification System Market. The report covers all the information on the global and regional markets including historical and future trends

WCM Investment Management LLC lifted its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 8.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,077,869 shares of the medical research companys stock after buying an additional 80,742 shares during the []

DUBLIN--(BUSINESS WIRE)--The "Bioinformatics Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com''s offering. The global bioinformatics market is expected to grow from $9.38 billion in 2020 to $10.57 billion in 2021 at a compound annual growth rate (CAGR) of 12.7%. The market is expected to reach $18.46 billion in 2025 at a CAGR of 15%. Major players in the bioinformatics market are Agilent Technologies, Illumina, QIAGEN, Affymetrix and

The report named Global Blood Viscometer Market Research Report offers a profound comprehension of the development and working of the Blood Viscometer market on a worldwide just as local premise. This appraisal report is the gathering of all the extensive

Here is how Thermo Fisher Scientific (TMO) and West Pharmaceutical Services (WST) have performed compared to their sector so far this year.

Halbert Hargrove Global Advisors LLC decreased its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 5.4% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,303 shares of the medical research companys stock after selling 75 shares during the period. Halbert Hargrove Global Advisors LLCs holdings in Thermo Fisher Scientific were worth $745,000 as of []

Folger Nolan Fleming Douglas Capital Management Inc. cut its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 4.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,323 shares of the medical research companys stock after selling 68 shares []

Trust Asset Management LLC grew its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 7.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,830 shares of the medical research companys stock after purchasing an additional 253 shares during the quarter. Trust Asset []

Round Table Services LLC purchased a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 379 shares of the medical research companys stock, valued at approximately $217,000. Other hedge funds and other []

Harvest Investment Services LLC lifted its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,392 shares of the medical research companys stock after purchasing an additional 17 shares during the quarter. Harvest []

Increased application areas of biobank samples, increased financing from commercial and government organisations for biobanking, increased genomic research efforts, and increased investment in R&D activities by various healthcare firms are all driving the global biobanking market forward. Due to increased adoption

The Biomarker Technologies Market research report provides broad, subjective bits of knowledge on the potential and specialty portions or regions displaying good growth. The Biomarker Technologies Market research report comprehensively investigates the current and developing business sector patterns and openings

Brokerages expect that Thermo Fisher Scientific Inc. (NYSE:TMO) will announce $4.82 earnings per share (EPS) for the current quarter, Zacks reports. Five analysts have made estimates for Thermo Fisher Scientifics earnings, with the lowest EPS estimate coming in at $4.78 and the highest estimate coming in at $4.87. Thermo Fisher Scientific posted earnings per share []